Skip to main content
Premium Trial:

Request an Annual Quote

Quantum Biosystems Raises ¥1B in Series C Financing Round

NEW YORK (GenomeWeb) – Quantum Biosystems said today that it has closed a ¥1 billion ($8.8 million) Series C financing round through the sale of preferred stock to Japanese venture capital company SBI Investment.

Quantum Biosystems, which was founded in January 2013 as a spinout of Osaka University, is developing a single-molecule sequencing technology intended to significantly reduce the cost and improve the accuracy of sequencing. The technology measures tunneling currents from DNA bases as the molecule passes by a sub-nanometer gap, and the company said that it has achieved resolution of one base pair with its method.

Quantum Biosystems said it plans to use the new funding to continue development of its sequencing technology by hiring additional scientists and expanding its academic and industry collaborations. It also said that it is specifically conducting research into using massively parallel nano-electrodes on a silicon device to detect current facilitated by electron tunneling and hopping.

The company last completed a funding round in 2015 for ¥2.4 billion.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.